Immunovant
IMVT
IMVT
118 hedge funds and large institutions have $322M invested in Immunovant in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 119 → 118 (-1)
11% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 45
Holders
118
Holding in Top 10
1
Calls
$22.9M
Puts
$1.12M
Top Buyers
| 1 | +$7.67M | |
| 2 | +$4.88M | |
| 3 | +$4.14M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.25M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$2.02M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$3.77M | |
| 3 | -$3.14M | |
| 4 |
Two Sigma Investments
New York
|
-$2.48M |
| 5 |
Two Sigma Advisers
New York
|
-$2.35M |